On October 28, 2025, Antegrade Medical Inc. announced the closing of a $7.3-million Series Seed financing. The financing was led by Sectoral Asset Management and had participation from Genesys Capital, Desjardins Capital, Seido Capital and private investors.
Genesys Capital invests in and builds companies in the high-growth sectors of biotechnology, pharmaceuticals and medical technology.
Osler, Hoskin & Harcourt LLP advised Genesys Capital with a team consisting of Gary Marshall (Emerging and High Growth Companies).
Key Contact
Gary Marshall
Partner, Emerging and High Growth Companies, Toronto
